Compound 1960
Identifiers
- Canonical SMILES:
CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)CCN1CCCC1
- IUPAC name:
N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methyl-3-(pyrrolidin-1-yl)propanamide
- InChi:
InChI=1S/C28H25Cl2F3N4O3/c1-36(25(38)6-9-37-7-2-3-8-37)15-16-10-18(29)12-21(26(16)39)24-13-19(22(14-34)27(40)35-24)20-11-17(28(31,32)33)4-5-23(20)30/h4-5,10-13,39H,2-3,6-9,15H2,1H3,(H,35,40)
- InChiKey:
JJLLLNSQFXKXDY-UHFFFAOYSA-N
External links
![]() 44431583 |
![]() CHEMBL428195 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Survivin dimer | 7.36 | cancer | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 592.13 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 2.55 | |||
TPSA | 95.07 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2007.03.042 | 23c | BIRC5 O15392 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 7.36 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5787 | 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | DB08705 | |
0.4481 | Losmapimod | DB12270 | |
0.4381 | JPC-3210 | DB15609 | |
0.4333 | Talnetant | DB06429 | |
0.4320 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE | DB07025 | |
0.4270 | Batefenterol | DB12526 | |
0.4167 | Tazemetostat | DB12887 | |
0.4148 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4125 | Garenoxacin | DB06160 | |
0.4083 | 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE | DB08358 | |
0.4064 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID | DB07265 | |
0.4053 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4042 | Milrinone | DB00235 | |
0.4041 | Topotecan | DB01030 | |
0.4025 | CPI-1205 | DB14581 |